ACLX Competitors & Alternatives
Compare Arcellx Inc with similar stocks in the same industry
Biotechnology
ACLX
Main Stock$115.07
Tradestie Score
57
Market Cap
$4.55B
Revenue Growth
-0.9%
Analyst Upside
-1.9%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 55 | Compare |
|
CYTK
Cytokinetics Inc.
|
$78.61
|
$6.68B | - | 58 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$105.78
|
$6.64B | - | 59 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$125.19
|
$6.38B | - | 51 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$19.13
|
$6.03B | - | 53 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$53.07
|
$6.02B | - | 55 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 57 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$212.17
|
$5.92B | - | 55 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$48.74
|
$5.80B | 16.1 | 57 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$324.77
|
$5.20B | 45.7 | 60 | Compare |
More ACLX Analysis
Data updated: Aug 04, 2026 | Industry: Biotechnology (SIC 2836)
231 stocks in this industry